PRSS41
gene geneOn this page
Also known as TESSP1
Summary
PRSS41 (serine protease 41, HGNC:30715) is a protein-coding gene on chromosome 16p13.3, encoding Serine protease 41 (Q7RTY9).
Predicted to enable serine-type endopeptidase activity. Predicted to be involved in proteolysis. Predicted to be located in plasma membrane.
Source: NCBI Gene 360226 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_001395501
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30715 |
| Approved symbol | PRSS41 |
| Name | serine protease 41 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TESSP1 |
| Ensembl gene | ENSG00000215148 |
| Ensembl biotype | protein_coding |
| Entrez | 360226 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000399677, ENST00000674256
RefSeq mRNA: 4 — MANE Select: NM_001395501
NM_001354586, NM_001395500, NM_001395501, NM_001395502
CCDS: CCDS92090, CCDS92091
Canonical transcript exons
ENST00000399677 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001609112 | 2799286 | 2799569 |
| ENSE00001663059 | 2804389 | 2804546 |
| ENSE00001722563 | 2798959 | 2799124 |
| ENSE00003898279 | 2798636 | 2798662 |
| ENSE00003898900 | 2804914 | 2805304 |
| ENSE00003978216 | 2798470 | 2798548 |
Expression profiles
Bgee: expression breadth broad, 27 present calls, max score 91.62.
Top tissues by expression
120 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.62 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 54.13 | gold quality |
| right testis | UBERON:0004534 | 53.05 | gold quality |
| testis | UBERON:0000473 | 49.33 | gold quality |
| left testis | UBERON:0004533 | 49.17 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 43.04 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 42.61 | gold quality |
| minor salivary gland | UBERON:0001830 | 41.96 | gold quality |
| blood | UBERON:0000178 | 41.57 | gold quality |
| granulocyte | CL:0000094 | 39.99 | gold quality |
| right lung | UBERON:0002167 | 39.08 | gold quality |
| bone marrow cell | CL:0002092 | 38.45 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| sural nerve | UBERON:0015488 | 37.17 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| monocyte | CL:0000576 | 35.91 | gold quality |
| leukocyte | CL:0000738 | 35.83 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 35.66 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| rectum | UBERON:0001052 | 34.39 | gold quality |
| bone marrow | UBERON:0002371 | 34.15 | gold quality |
| vermiform appendix | UBERON:0001154 | 33.69 | silver quality |
| placenta | UBERON:0001987 | 33.64 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| duodenum | UBERON:0002114 | 33.19 | silver quality |
| tonsil | UBERON:0002372 | 32.75 | silver quality |
| prefrontal cortex | UBERON:0000451 | 30.14 | gold quality |
| liver | UBERON:0002107 | 30.12 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.99 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Prss41 | ENSMUSG00000024114 |
| rattus_norvegicus | Prss41 | ENSRNOG00000033690 |
| drosophila_melanogaster | Sb | FBGN0003319 |
| drosophila_melanogaster | CG17242 | FBGN0250841 |
Paralogs (17): PRSS22 (ENSG00000005001), PRSS21 (ENSG00000007038), TMPRSS11E (ENSG00000087128), HPN (ENSG00000105707), TMPRSS13 (ENSG00000137747), ST14 (ENSG00000149418), TMPRSS11D (ENSG00000153802), TMPRSS15 (ENSG00000154646), TMPRSS3 (ENSG00000160183), TMPRSS5 (ENSG00000166682), TMPRSS7 (ENSG00000176040), TMPRSS9 (ENSG00000178297), TMPRSS2 (ENSG00000184012), TMPRSS11B (ENSG00000185873), TMPRSS6 (ENSG00000187045), TMPRSS11A (ENSG00000187054), TMPRSS11F (ENSG00000198092)
Protein
Protein identifiers
Serine protease 41 — Q7RTY9 (reviewed: Q7RTY9)
Alternative names: Testis serine protease 1
All UniProt accessions (2): A0A6I8PU99, A0A6Q8NYF4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cell membrane.
Post-translational modifications. N-glycosylated.
Similarity. Belongs to the peptidase S1 family.
RefSeq proteins (4): NP_001341515, NP_001382429, NP_001382430, NP_001382431 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001254 | Trypsin_dom | Domain |
| IPR001314 | Peptidase_S1A | Family |
| IPR009003 | Peptidase_S1_PA | Homologous_superfamily |
| IPR018114 | TRYPSIN_HIS | Active_site |
| IPR033116 | TRYPSIN_SER | Active_site |
| IPR043504 |
Pfam: PF00089
UniProt features (16 total): disulfide bond 4, active site 3, propeptide 2, glycosylation site 2, signal peptide 1, sequence variant 1, chain 1, domain 1, lipid moiety-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7RTY9-F1 | 84.18 | 0.59 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 95 (charge relay system); 147 (charge relay system); 249 (charge relay system)
Post-translational modifications (1): 299
Disulfide bonds (4): 80–96, 181–255, 215–234, 245–273
Glycosylation sites (2): 284, 211
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-163125 | Post-translational modification: synthesis of GPI-anchored proteins |
MSigDB gene sets: 38 (showing top):
GOBP_PROTEIN_MATURATION, GOCC_SIDE_OF_MEMBRANE, SANSOM_APC_TARGETS, GOBP_PROTEOLYSIS, SANSOM_APC_TARGETS_REQUIRE_MYC, GOMF_PEPTIDASE_ACTIVITY, GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C, GOBP_PROTEIN_PROCESSING, REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS, GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN, GSE17721_CTRL_VS_CPG_1H_BMDC_DN, GSE17721_LPS_VS_CPG_1H_BMDC_DN, DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS
GO Biological Process (1): proteolysis (GO:0006508)
GO Molecular Function (4): serine-type endopeptidase activity (GO:0004252), serine-type peptidase activity (GO:0008236), peptidase activity (GO:0008233), hydrolase activity (GO:0016787)
GO Cellular Component (4): extracellular region (GO:0005576), plasma membrane (GO:0005886), intracellular organelle (GO:0043229), side of membrane (GO:0098552)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| membrane | 2 |
| protein metabolic process | 1 |
| endopeptidase activity | 1 |
| serine-type peptidase activity | 1 |
| peptidase activity | 1 |
| serine hydrolase activity | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| catalytic activity | 1 |
| cell periphery | 1 |
| intracellular anatomical structure | 1 |
| organelle | 1 |
| leaflet of membrane bilayer | 1 |
Protein interactions and networks
STRING
562 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRSS41 | PRSS37 | A4D1T9 | 403 |
| PRSS41 | SPINT1 | O43278 | 402 |
| PRSS41 | PLD1 | Q13393 | 401 |
| PRSS41 | FLYWCH1 | Q4VC44 | 398 |
| PRSS41 | FLYWCH2 | Q96CP2 | 360 |
| PRSS41 | SRRM2 | Q9UQ35 | 355 |
| PRSS41 | MTPN | P58546 | 354 |
| PRSS41 | TMEM235 | A6NFC5 | 351 |
| PRSS41 | BICDL2 | A1A5D9 | 346 |
| PRSS41 | HCFC1R1 | Q9NWW0 | 345 |
| PRSS41 | PURG | Q9UJV8 | 345 |
| PRSS41 | SPINT2 | O43291 | 335 |
| PRSS41 | KCTD5 | Q9NXV2 | 331 |
| PRSS41 | PAQR4 | Q8N4S7 | 331 |
| PRSS41 | DEFB130A | P0DP74 | 321 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| AFG2A | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| POLD3 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): PRSS41 (Affinity Capture-MS), TPSG1 (Negative Genetic)
ESM2 similar proteins: A1L453, A2VE36, A6NIE9, A8MTI9, E5RG02, O43240, O70169, P09582, P50343, P83748, Q14B25, Q14BX2, Q16651, Q3UKY7, Q3V0Q7, Q402U7, Q571E5, Q5FBW1, Q5K2P8, Q5K2P9, Q5M8S2, Q6AXZ6, Q6BEA2, Q6IE62, Q6IE63, Q6UWB4, Q76B45, Q76HL1, Q7RTY3, Q7RTY5, Q7RTY9, Q7Z5A4, Q8BJR6, Q8BLH5, Q8K4I7, Q8VIF2, Q920S2, Q99MS4, Q9BQR3, Q9D9M0
Diamond homologs: A0A126GUP6, A0A182C2Z2, A0A1S4H5M5, A8JUP7, B5U2W0, B7YZU2, F5HKX0, O15393, O35453, O60235, O60259, O97366, P00774, P03951, P03952, P05049, P05981, P08419, P09871, P10323, P13582, P14272, P21902, P23578, P25155, P26262, P28175, P29293, P31394, P33587, P35035, P35036, P35037, P35039, P35041, P35045, P35046, P35047, P40313, P48038
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2089 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:2799547:G:C | W186C | 0.997 |
| 16:2799547:G:T | W186C | 0.997 |
| 16:2804508:T:A | C234S | 0.997 |
| 16:2804509:G:C | C234S | 0.997 |
| 16:2804451:T:A | C215S | 0.996 |
| 16:2804452:G:C | C215S | 0.996 |
| 16:2799032:G:C | W68C | 0.995 |
| 16:2799032:G:T | W68C | 0.995 |
| 16:2804958:G:C | W261C | 0.994 |
| 16:2804958:G:T | W261C | 0.994 |
| 16:2804509:G:A | C234Y | 0.993 |
| 16:2799030:T:A | W68R | 0.992 |
| 16:2799030:T:C | W68R | 0.992 |
| 16:2799075:A:C | S83R | 0.992 |
| 16:2799077:C:A | S83R | 0.992 |
| 16:2799077:C:G | S83R | 0.992 |
| 16:2799307:G:C | W106C | 0.992 |
| 16:2799307:G:T | W106C | 0.992 |
| 16:2799312:T:A | V108D | 0.992 |
| 16:2804510:T:G | C234W | 0.992 |
| 16:2804938:T:A | C255S | 0.992 |
| 16:2804939:G:C | C255S | 0.992 |
| 16:2799026:G:C | W66C | 0.991 |
| 16:2799026:G:T | W66C | 0.991 |
| 16:2804452:G:A | C215Y | 0.991 |
| 16:2804508:T:C | C234R | 0.991 |
| 16:2804977:A:C | S268R | 0.990 |
| 16:2804979:C:A | S268R | 0.990 |
| 16:2804979:C:G | S268R | 0.990 |
| 16:2799532:C:G | C181W | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000172535 (16:2802911 T>A,C), RS1000198089 (16:2802753 C>T), RS1000462849 (16:2798015 C>T), RS1000578365 (16:2798313 C>T), RS1001189476 (16:2802593 T>A,C), RS1001509950 (16:2797133 G>A,C), RS1001681215 (16:2797828 T>C), RS1001731051 (16:2803594 T>C), RS1001795837 (16:2797970 G>A,C), RS1001915639 (16:2798241 G>A), RS1001968148 (16:2804562 C>G,T), RS1001981595 (16:2796926 G>A), RS1002061629 (16:2804821 A>G), RS1002356456 (16:2802251 G>A,C), RS1002568609 (16:2800048 ACAT>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | affects methylation, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Ozone | affects methylation, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.